Absci Takes Its Generative AI Antibody Design Platform To Europe Generative AI technology, like ChatGPT, is disrupting many industries
including biopharma. For example, Absci is using AI to design & validate de novo antibodies. And now Absci is expanding its
operation to Europe to disrupt the protein-based therapeutics market.